Home  >  Products  >  PRAC (prostate cancer susceptibility candidate) Blocking Peptide (the N terminal of PRAC)(100ug)
PRAC (prostate cancer susceptibility candidate) Blocking Peptide (the N terminal of PRAC)(100ug)

PRAC (prostate cancer susceptibility candidate) Blocking Peptide (the N terminal of PRAC)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PRAC Antibody (ARP60550_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60550
Size: 100ug
Weight: 6kDa
Gene: 84366
Format: Lyophilized powder
Target: This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus.
Alternative names: C17orf92; MGC32520
See Full Product Listings >